WARSAW, Ind., Feb. 17, 2011 /PRNewswire/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today preliminary unaudited revenue for the full year ended January 1, 2011.
Symmetry anticipates full year 2010 revenue of approximately $361 million, in line with previously issued guidance of $360 to $364 million.
For the full year 2011, the Company issued revenue guidance of $363 to $383 million, representing annual growth of approximately 1% to 6%.
Symmetry announced anticipated full year 2010 revenue and 2011 revenue guidance in advance of the Company’s Investor Breakfast, which is scheduled for 7:30 a.m. PT on Thursday, February 17, 2011. The Investor Breakfast is being held in conjunction with the American Association of Orthopedic Surgeons (AAOS) Annual Meeting in San Diego, CA. A live Web cast of the Investor Breakfast will be available online from the investor relations page of the Company’s corporate Web site at www.symmetrymedical.com. After the live Web cast, a replay will remain available on Symmetry Medical’s Web site through March 17, 2011.
Symmetry will announce complete financial and operating details of its fourth quarter and the full year ended January 1, 2011, as well as 2011 EPS guidance, before the market opens on Thursday, February 24, 2011. The Company will host an accompanying conference call at 8:00 a.m. ET on Thursday, February 24, 2011.
A live Web cast of the conference call will be available online from the investor relations page of the Company’s corporate Web site at www.symmetrymedical.com. The dial-in numbers are (800) 573-4840 for domestic callers and (617) 224-4326 for international. The reservation number for both is 65718196.After the live Web cast, the call will remain available on Symmetry Medical’s Web site through May 24, 2011. In addition, a telephonic replay of the call will be available until March 10, 2011. The replay numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Please use reservation code 64799370.
About Symmetry Medical Inc.
Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.
Forward-Looking Statements
Statements in the press release regarding Symmetry Medical Inc.'s business which are not historical facts may be “forward-looking statements” that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as “may,” “might,” “will,” “should,” “expect,” “believe,” “anticipate,” “plan,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the “Risk Factors” and “Forward Looking-Statements” sections in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company’s other filings with the SEC, which are available on the SEC’s Web site at www.sec.gov.
Contact: Symmetry Medical Inc. Fred L. Hite Senior Vice President Chief Financial Officer (574) 371-2218 | Investors: The Ruth Group Nick Laudico/Zack Kubow (646) 536-7030/7020 Media: Jason Rando The Ruth Group (646) 536-7025 | |
SOURCE Symmetry Medical Inc.
